SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing significant market activity and heightened community discourse driven by persistent acquisition rumors and notable institutional volume in after-hours trading. Traders are actively debating the stock's valuation relative to its rare disease pipeline, while observing unconventional trading patterns that have fueled speculation of a potential buyout.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is trending as investors grapple with heightened market volatility driven by escalating geopolitical tensions and institutional debates over Bitcoin's long-term utility as a hedge. The community remains deeply divided, with bulls pointing to historical price cycles and potential regulatory breakthroughs like the Clarity Act, while bears are emphasizing downside risks linked to broader economic uncertainty and shifting institutional flow dynamics.

Sharplink, Inc. is an institutional-grade Ethereum treasury platform that provides public market investors with exposure to ETH. The platform focuses on Ethereum, which is used in various stablecoin, tokenized real-world asset, and decentralized finance settlement applications. This allows for native yield generation and potential network growth opportunities with ETH. The company is also involved in the online affiliate marketing business. The company was founded in 2019 and is headquartered in Miami, FL.

Sharplink Inc.

SharpLink Gaming Ltd

SharpLink Gaming is under intense scrutiny as shareholders react to the termination of a material asset management agreement, fueling widespread debate over the company's long-term viability and crypto-treasury strategy. The community is heavily polarized, with vocal investors expressing extreme frustration over persistent share price dilution and underperformance while others remain optimistic, citing the company's significant Ethereum holdings and staking yield as a deep-value opportunity.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is capturing market attention as essential DeFi infrastructure, bolstered by a high-profile partnership with the U.S. Department of Commerce to provide macroeconomic data on-chain. Investors are actively discussing the project's institutional-grade data model, its revenue-generating potential through protocol buybacks, and its critical role in the expanding Real World Asset (RWA) narrative.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community speculates on a major upcoming partnership announcement, with many pointing to a connection with Stellar or a potential collaboration with Ripple/XRP at an upcoming industry event. Investors are actively debating the project's long-term utility in global payroll and real-world adoption, balancing high-conviction sentiment against skepticism regarding its price performance and market volatility.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals (REGN) is currently seeing heightened trading activity as investors react to regulatory challenges at a third-party manufacturing facility, which has triggered delays for key products like Eylea HD. While sentiment remains divided due to these supply chain hurdles and competitive pressure in the ophthalmology space, the community is closely monitoring upcoming earnings and pipeline developments, with many bulls pointing to strong revenue growth from blockbusters like Dupixent and Libtayo as reasons for long-term optimism.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is currently trending due to intense volatility following a quarterly earnings report that featured a strong double beat on top and bottom lines but provided cautious forward revenue guidance. The community is actively debating whether the double-digit price decline is a baseless overreaction caused by market makers or a justified correction given the stock's high valuation and competitive concerns within the AI infrastructure sector.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh the potential impact of looming pharmaceutical tariffs, which are pushing the company to increase its U.S. manufacturing footprint. Simultaneously, the community is actively debating the company's aggressive M&A strategy, particularly its focus on expanding oncology and T-cell engager therapy pipelines, while keeping a watchful eye on patent litigation risks.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The DJIA is currently oscillating amidst a complex landscape of geopolitical tension, cooling energy prices, and mixed economic data that have investors scrutinizing the sustainability of recent market highs. Market participants remain focused on potential Fed policy shifts and the impact of upcoming earnings cycles, while community discussions continue to center on how prolonged global instability could influence corporate valuation multiples.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is seeing heightened volatility as community sentiment remains deeply divided over Cathie Wood's aggressive trading strategies, with critics pointing to its long-term underperformance while others track her frequent shifts in positions among speculative tech and crypto-linked holdings. Discussions center on the fund's role as a high-beta barometer for market risk, with traders actively debating its recent technical breakdowns, rotational selling, and the impact of her latest rebalancing moves on sentiment for growth-focused assets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Smallcap and midcaps are offering pockets of opportunities, driven by technical patterns, strong volumes and RSI strength.&nbsp;SEBI-registered analyst&nbsp;<a href="https://stocktwits.com/Vinaytaparia">Vinay Taparia</a> is bullish on select breakout stocks across sectors such as healthcare, engineering, and metals.&nbsp;Let’s take a look at his recommendations:Shalby<a href="https://stocktwits.com/symbol/SHALBY.NSE">Shalby</a> has broken out from a small base at the bottom. Taparia noted that the stock has broken out of its one and a half month range on the upside. Its Relative Strength Index (RSI) is also indicating strength. He suggested buying on declines at ₹182 for a target of ₹210-₹225 and ₹240; and exit on close below ₹176.<stembedurl>https://stocktwits.com/Vinaytaparia/message/621007215</stembedurl>Shalby shares have fallen 14% year-to-date (YTD).Bombay Burmah Trading CorporationBombay Burmah Trading (<a href="https://stocktwits.com/symbol/BBTC.NSE">BBTC)</a> shares saw a small breakout on Tuesday, driven by good volumes. Taparia noted that the stock is also making lower lows, which he believes is a good sign. He suggested buying at ₹1,950 on a decline for targets of ₹2,150 and ₹2,340, and exiting on a close below ₹1,900. The recommendation is for a time frame of three to six months.<stembedurl>https://stocktwits.com/Vinaytaparia/message/621016598</stembedurl>BBTC shares have fallen 6% year-to-date (YTD).Kirloskar Industries<a href="https://stocktwits.com/symbol/KIRLOSIND.NSE">Kirloskar Industries</a> has given a superb breakout with good volume, Taparia noted. Its RSI is also trending upward. He suggested buying at ₹4,250 on declines with a target of ₹4,850-₹5,300, and exit on closing below ₹4,100.<stembedurl>https://stocktwits.com/Vinaytaparia/message/621089554</stembedurl>Kirloskar Industries shares have risen 3% year-to-date (YTD).Bharat Gears<a href="https://stocktwits.com/symbol/BHARATGEAR.NSE">Bharat Gears&nbsp;</a>saw a breakout on Tuesday, forming a bullish candle with significant volume. Taparia suggested buying it at&nbsp;₹90 on a decline for targets of ₹120 and ₹130, and exiting on a close below&nbsp;₹85.<stembedurl>https://stocktwits.com/Vinaytaparia/message/621090815</stembedurl>Bharat Gears shares have fallen 2% year-to-date (YTD).Vintage Coffee &amp; Beverages<a href="https://stocktwits.com/symbol/VINCOFE.NSE">Vintage Coffee</a> reached an all-time high on Tuesday, accompanied by strong volume. He suggested buying at ₹136 on a decline for targets of ₹160-₹175, and exiting on a close below ₹132.<stembedurl>https://stocktwits.com/Vinaytaparia/message/621091317</stembedurl>Vintage Coffee shares have surged 26% year-to-date (YTD).Shyam Metalics &amp; Energy&nbsp;<a href="https://stocktwits.com/symbol/SHYAMMETL.NSE">Shyam Metalics&nbsp;</a>formed a good bullish candle and closed above a small falling trend line on Tuesday. Taparia suggested buying at ₹860 on a decline for targets of ₹895-₹950 and ₹1,000. A close above ₹896 will form an inverted head and shoulder pattern breakout. He suggested exiting on close below ₹855.<stembedurl>https://stocktwits.com/Vinaytaparia/message/621093328</stembedurl>Shyam Metalics shares have surged 24% year-to-date (YTD).EMS<a href="https://stocktwits.com/symbol/EMSLIMITED.NSE">EMS</a> has consistently taken support at the upward-moving trend line, and on Tuesday, it gave a small breakout. Stock can be bought at the current market price for targets of ₹682 and ₹750, and exit on closing below ₹595.<stembedurl>https://stocktwits.com/Vinaytaparia/message/621094425</stembedurl>EMS shares have declined 28% year-to-date (YTD).Rupa &amp; Company<a href="https://stocktwits.com/symbol/RUPA.NSE">Rupa&nbsp;</a>witnessed a superb cup and handle breakout on Tuesday; it can be bought at ₹215 on decline for targets of ₹260 and ₹290; exit on closing below ₹210.<stembedurl>https://stocktwits.com/Vinaytaparia/message/621100096</stembedurl>Rupa shares have declined 8% year-to-date (YTD).For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

From Shalby, BBTC To Kirloskar, Shyam Metalics: SEBI RA Recommends These 8 Stocks To Watch

The analyst highlights clear breakout patterns and volume-backed moves as bullish indicators.

Equity

The analyst highlights clear breakout patterns and volume-backed moves as bullish indicators.


Vintage Coffee & Beverages Ltd. is a holding company, which engages in the business of trading. It operates manufacturing facilities for instant coffee. The company was founded on April 25, 1980 and is headquartered in Hyderabad, India.

Current Price	133.95
Prev Close	135.00
Open	134.60
Dividend Yield	0.10%
50-Day Moving Average	140.50
Beta	0.30
Avg. Volume	2.51M
PE Ratio	27.02

52-Week High	179.85
52-Week Low	82.81
Market Capitalization	19.22B
EPS (Annual)	3.19
Price to Book	3.65
Revenue Per Employee	308.52M

VINCOFE.NSE
Vintage Coffee & Beverages Ltd

Feed

News

Sentiment

Fundamentals

Info

Latest VINCOFE.NSE News

VINCOFE.NSEVintage Coffee & Beverages Ltd